Innate immune activation in neurodegenerative disease
The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Abstract
The triggering of innate immune mechanisms is emerging as a crucial component of major neurodegenerative diseases. Microglia and other cell types in the brain can be activated in response to misfolded proteins or aberrantly localized nucleic acids. This diverts microglia from their physiological and beneficial functions, and leads to their sustained release of pro-inflammatory mediators. In this Review, we discuss how the activation of innate immune signalling pathways - in particular, the NOD-, LRR- and pyrin domain-containing 3 (NLRP3) inflammasome - by aberrant host proteins may be a common step in the development of diverse neurodegenerative disorders. During chronic activation of microglia, the sustained exposure of neurons to pro-inflammatory mediators can cause neuronal dysfunction and contribute to cell death. As chronic neuroinflammation is observed at relatively early stages of neurodegenerative disease, targeting the mechanisms that drive this process may be useful for diagnostic and therapeutic purposes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is corollary evidence for inflammation in FTD (Heneka et al., 2014), from genetic (Guerreiro et al., 2013; Rayaprolu et al., 2013; Broce et al., 2018), CSF (Sjogren et al., 2004; Woollacott et al., 2018), epidemiology (Miller et al., 2013, 2016), post-mortem (Venneti et al., 2008; Lant et al., 2014) and animal studies (Yoshiyama et al., 2007; Bhaskar et al., 2010; Yin et al., 2010).”
From Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum (2020) · cites this paper as Heneka et al., 2014
In the citing paper
“in AD, the chronic release of DAMPs, mitochondrial-released DAMPs and pro-inflammatory molecules contributes to the onset and progression of neurodegeneration [57, 76, 97, 149, 194, 270, 304, 333, 345]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“This is thought to divert microglia from performing house-keeping functions, promoting a low-grade inflammatory state and CNS damage [149, 333]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“studies have shown that cellular aging, infection, traumatic brain injury, systemic inflammation, chronic inflammatory diseases, obesity and poor oral health occurring during middle adulthood can lead to increased pro-inflammatory signals in the periphery, which may contribute to glial activation and the onset and/or perpetuation of neurodegeneration [93, 105, 149, 333]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“TLRs and associated signaling pathways contribute to both injurious and regenerative processes in CNS diseases (33–35).”
From UNC93B1 Is Widely Expressed in the Murine CNS and Is Required for Neuroinflammation and Neuronal Injury Induced by MicroRNA let-7b (2021) · cites this paper as [33]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Cited by
Items 501–600 of 1,004
Personalized genetics of the cholinergic blockade of neuroinflammation
Simchovitz, A., Heneka, M. T., & Soreq, H. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13928 · Cited by 39
Self-citationGauthier, S., Zhang, H., Ng, K. P., Pascoal, T. A., & Rosa-Neto, P. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0117-9 · Cited by 39
“In addition to hallmark AD neuropathological features such as amyloid (Aβ) plaques, neurofibrillary tangles and neuronal degeneration, there is a growing body of evidence supporting neuroinflammation as an important player in the pathogenesis of AD [79, 80].”
Li, T., Yang, Z., Li, S., Cheng, C., Shen, B., & Le, W. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00392 · Cited by 39
Hyperactive Innate Immunity Causes Degeneration of Dopamine Neurons upon Altering Activity of Cdk5
Shukla, A. K., Spurrier, J. M., Kuzina, I., & Giniger, E. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109258 · Cited by 39
Alleviation of symptoms of Alzheimer's disease by diminishing Aβ neurotoxicity and neuroinflammation
Yang, T., Zhu, Z., Yin, E., Wang, Y., Zhang, C., Yuan, H., Zhang, H., Jin, S., Guo, Z., & Wang, X. (2019) · Chemical Science · doi:10.1039/c9sc03042e · Cited by 39
Wen, M., Ding, L., Zhang, L., Zhang, T., Yanagita, T., Wang, Y., & Xue, C. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b05947 · Cited by 42
Zhang, C., Hu, L., Liu, D., Huang, J., & Lin, W. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00760 · Cited by 42
“In fact, it inhibits the neuronal regeneration (Heneka and Kummer, 2014; Schain and Kreisl, 2017).”
BackgroundElectroconvulsive stimulation attenuates chronic neuroinflammation
Goldfarb, S., Fainstein, N., & Ben‐Hur, T. (2020) · JCI Insight · doi:10.1172/jci.insight.137028 · Cited by 46
“The brain’s innate immune system, represented mainly by microglia, plays a leading role in chronic neuroinflammation– induced brain injury (2).”
BackgroundWu‐Chung, E. L., Leal, S. L., Denny, B. T., Cheng, S. L., & Fagundes, C. P. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.12.010 · Cited by 55
Tóth, K., Lénárt, N., Berki, P., Fekete, R., Szabadits, E., Pósfai, B., Cserép, C., Alatshan, A., Benkő, S., Kiss, D. K., et al. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001526 · Cited by 40
“Microglia are the primary source of inflammatory cytokines in a number of neuropathologies, and IL-1β, also produced by microglia, is a key proinflammatory cytokine regulating the brain’s cytokine network [42,43].”
BackgroundUnleashing cell-penetrating peptide applications for immunotherapy
Koo, J., Kim, G., Nam, K.-H., & Choi, J. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.03.010 · Cited by 45
Understanding neuron-glia crosstalk and biological clocks in insomnia
Carvalhas-Almeida, C., Serra, J., Moita, J. J., Cavadas, C., & Álvaro, A. R. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105100 · Cited by 43
“Astrocytes also play a role in the neuroinflammatory responses to brain injuries through astrogliosis, which has positive and negative inflammatory effects in surrounding cells, particularly microglia that interacts extensively with astrocytes [91, 204, 205].”
BackgroundZou, Y., Jiang, J., Li, Y., Ding, X., Fang, F., & Chen, L. (2024) · Inflammation · doi:10.1007/s10753-024-01997-5 · Cited by 44
“Retinal neuroinflammation is a crucial aspect of AMD [45, 46].”
A transcriptional perspective on human macrophage biology
Schultze, J. L., Freeman, T. C., Hume, D. A., & Latz, E. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.02.001 · Cited by 44
Self-citationYu, P., Liu, B., Pei, S., Zheng, D., Wang, Z., Ji, T., Pan, S., Shen, H., & Wang, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00905 · Cited by 42
Liu, P., Zhao, B., Wei, M., Li, Y., Liu, J., Ma, L., Shang, S., Huo, K., Wang, J., Li, R., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191317 · Cited by 42
Abrogation of type-I interferon signalling alters the microglial response to Aβ1–42
Moore, Z., Mobilio, F., Walker, F. R., Taylor, J. M., & Crack, P. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-59917-0 · Cited by 45
Inflammation and Parkinson's disease pathogenesis: Mechanisms and therapeutic insight
Forloni, G., Vitola, P. L., Cerovic, M., & Balducci, C. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.11.001 · Cited by 45
Tröscher, A. R., Sakaraki, E., Mair, K. M., Köck, U., Rácz, Á., Borger, V., Cloppenborg, T., Becker, A. J., Bien, C. G., & Bauer, J. (2021) · Epilepsia · doi:10.1111/epi.16914 · Cited by 40
Inflammation: A Mediator Between Hypertension and Neurodegenerative Diseases
Youwakim, J., & Girouard, H. (2021) · American Journal of Hypertension · doi:10.1093/ajh/hpab094 · Cited by 43
Xiao, L., Wang, M., Shi, Y., Xu, Y., Gao, Y., Zhang, W., Wu, Y., Deng, H., Pan, W., Wang, W., et al. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220830115018 · Cited by 41
“Inflammasomes are oligomeric multiprotein complexes distributed in the cytoplasm that play a vital role in the innate immune response to central nervous system (CNS) disease [23, 24].”
Zhang, M., Qian, X., Hu, J., Zhang, Y., Lin, X., Hai, W., Shi, K., Jiang, X., Li, Y., Tang, H., et al. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-023-06446-3 · Cited by 43
“This response may subsequently be amplified by additional immunostimulatory molecules released or generated during ongoing neuroinflammation [39].”
The dual nature of neuroinflammation in networked brain
Müller, L., Benedetto, S. D., & Müller, V. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1659947 · Cited by 50
“Misfolded amyloid-b (A b ) peptides activate microglia via receptors including TLRs and scavenger receptors, promoting a sustained in fl ammatory state (42, 43).”
for the ELGAN Study Investigators, Dammann, O., Allred, E. N., Fichorova, R. N., Kuban, K., O’Shea, T. M., & Leviton, A. (2015) · Inflammation · doi:10.1007/s10753-015-0293-z · Cited by 37
Das, A., Arifuzzaman, S., Yoon, T., Kim, S. H., Chai, J. C., Lee, Y. S., Jung, K. H., & Chai, Y. G. (2017) · Scientific Reports · doi:10.1038/s41598-017-06914-5 · Cited by 39
“We then exposed the PM and BV-2 microglial cells to the following four different conditions: (1) untreated, (2) GSK-J4, (3) LPS, and (4) GSK-J4 + LPS.”
MethodDeora, V., Albornoz, E. A., Zhu, K., Woodruff, T. M., & Gordon, R. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9754-5 · Cited by 37
Involvement of Innate Immune System in Late Stages of Inherited Photoreceptor Degeneration
Sudharsan, R., Beiting, D. P., Aguirre, G. D., & Beltran, W. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-18236-7 · Cited by 37
Dubey, H., Gulati, K., & Ray, A. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0049 · Cited by 36
Zhong, Q., Yu, H. M., Huang, C., Zhong, J., Wang, H., Xu, J., & Cheng, Y. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.10.017 · Cited by 38
“Depression and a variety of other psychiatric diseases are typically accompanied by neuroinflammation (Maes et al., 2009; Blandini, 2013; Heneka et al., 2014).”
Development of covalent NLRP3 inflammasome inhibitors: Chemistry and biological activity
Bertinaria, M., Gastaldi, S., Marini, E., & Giorgis, M. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.11.013 · Cited by 40
“The overexpression of NLRP3 and the activation of the NLRP3-mediated inflammatory response has been observed in recent years in several neurodegenerative diseases [24,25], such as amiotrophic lateral sclerosis (ALS) [26], Alzheimer’s disease [27-29] and Parkinson’s disease [30-”
BackgroundWassouf, Z., & Schulze-Hentrich, J. M. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14787 · Cited by 38
Phosphodiesterase 7 Regulation in Cellular and Rodent Models of Parkinson’s Disease
Morales-Garcia, J. A., Alonso‐Gil, S., Santos, Á., & Pérez‐Castillo, A. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01745-z · Cited by 38
CNS-localized myeloid cells capture living invading T cells during neuroinflammation
Wasser, B., Luchtman, D. W., Löffel, J. T., Robohm, K., Birkner, K., Stroh, A., Vogelaar, C. F., Zipp, F., & Bittner, S. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190812 · Cited by 39
SIRT1 activation by minocycline on regulation of microglial polarization homeostasis
Wu, L.-H., Huang, B.-R., Lai, S.-W., Lin, C., Lin, H.-Y., Yang, L.-Y., & Lu, D.-Y. (2020) · Aging · doi:10.18632/aging.103542 · Cited by 36
“Microglial cells, which reside in the central nervous system, remove accumulating debris from the brain and are pivotal for maintaining tissue homeostasis, neuronal integrity, and network functioning [1].”
BackgroundZaychik, Y., Fainstein, N., Touloumi, O., Goldberg, Y., Hamdi, L., Segal, S., Nabat, H., Zoidou, S., Grigoriadis, N., Katz, A., et al. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.640724 · Cited by 44
“NO and ROS play a central role in microglial neurotoxicity (Heneka et al., 2014).”
BackgroundRepurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
Jung, Y. J., Tweedie, D., Scerba, M. T., Kim, D. S., Palmas, M. F., Pisanu, A., Carta, A. R., & Greig, N. H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.656921 · Cited by 38
Buck, E., Bayer, H., Lindenberg, K. S., Hanselmann, J., Pasquarelli, N., Ludolph, A. C., Weydt, P., & Witting, A. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00156 · Cited by 36
“Inflammatory processes in human macrophages are also mediated by SIRT3 (Traba et al., 2015) and inflammation is another shared feature of neurodegenerative diseases, including ALS and HD (Heneka et al., 2014).”
BackgroundIshimoto, T., Nakamichi, N., Nishijima, H., Masuo, Y., & Kato, Y. (2018) · Neurochemical Research · doi:10.1007/s11064-017-2350-5 · Cited by 36
“Membrane receptor signaling, including purinergic receptor signaling, is known to regulate microglial activation [10, 28, 29], whereas the regulation by membrane transporters has remained largely unclear.”
BackgroundWang, H., Wang, Z., Gao, H., Liu, J., Qiao, Z., Zhao, B., Liang, Z., Jiang, B., Zhang, L., & Zhang, Y. (2022) · Chemical Science · doi:10.1039/d2sc04087e · Cited by 42
Richards, R. I., Robertson, S. A., O'Keefe, L. V., Fornarino, D., Scott, A., Lardelli, M., & Baune, B. T. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00193 · Cited by 36
“However this same sensitive innate surveillance system is more readily able to detect genetic and/or environmental danger and damage signals in the nervous system, leading to increased susceptibility to neurodegenerative disease.”
BackgroundTong, L., Prieto, G. A., & Cotman, C. W. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1158-9 · Cited by 40
“This cascade, which conveys IL-1β signal from membrane to actin cytoskeleton and AMPA receptor insertion, may represent an underlying mechanism that contributes to IL-1β-dependent inflammation-induced LTP deficits in in vivo models of AD where glia activation increases IL-1β [1, 11].”
BackgroundXu, Z., Liu, C., Wang, R., Gao, X.-R., Hao, C., & Liu, C. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108558 · Cited by 38
Piancone, F., Saresella, M., Rosa, F. L., Marventano, I., Meloni, M., Navarro, J., & Clerici, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.639646 · Cited by 39
Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance
Martini, S., Gemma, A., Ferrari, M., Cosentino, M., & Marino, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043125 · Cited by 41
“Activated microglia commonly upregulates expression of pattern recognition receptors (PRRs), inducing an inflammatory response and secretion of proinflammatory cytokines, including IFNs [200,201].”
BackgroundThe Role of Diet, Additives, and Antibiotics in Metabolic Endotoxemia and Chronic Diseases
Park, J., Park, H., Kim, Y., & Park, M. (2024) · Metabolites · doi:10.3390/metabo14120704 · Cited by 43
Lascio, S. D., Fornasari, D., & Benfante, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073463 · Cited by 41
CNS and CNS diseases in relation to their immune system
Xu, J., Ma, C.-Y., Hua, M., Li, J., Xiang, Z., & Wu, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1063928 · Cited by 46
Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
Wang, Z., Wang, Q., Li, S., Li, X.-J., Yang, W., & He, D. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1065183 · Cited by 35
Borbély, E., Varga, V. É., Szögi, T., Schuster, I., Bozsó, Z., Penke, B., & Fülöp, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052514 · Cited by 39
de Koning, R. M., Kuzminskaite, E., Vinkers, C. H., Giltay, E. J., & Penninx, B. W. J. H. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.07.158 · Cited by 42
“, 2013), neurodegeneration (Heneka et al., 2014), and cancer (Taniguchi and Karin, 2018), to depression (Miller and Raison, 2016).”
Mercan, D., & Heneka, M. T. (2022) · Biology · doi:10.3390/biology11121822 · Cited by 45
“In this activated state, the phagocytic activity of microglia is enhanced [52,57].”
BackgroundSelf-citationFerroptosis and Pyroptosis in Epilepsy
Feng, F., Luo, R., Mu, D., & Cai, Q. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04018-6 · Cited by 41
“High intracellular iron activates pro-inflammatory M1 macrophages, accompanied by a decrease in anti-inflammatory M2 macrophages [86].”
Early host defense against virus infections
Paludan, S. R., Pradeu, T., Pichlmair, A., Wray, K. B., Mikkelsen, J. G., Olagnier, D. P., & Mogensen, T. H. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115070 · Cited by 40
Neniskyte, U., Fricker, M., & Brown, G. C. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.06.005 · Cited by 34
Intestinal bacterial biofilms modulate mucosal immune responses
Sartor, R. B. (2018) · Journal of Immunological Sciences · doi:10.29245/2578-3009/2018/2.1122 · Cited by 41
Microglia changes associated to Alzheimer's disease pathology in aged chimpanzees
Edler, M. K., Sherwood, C. C., Meindl, R. S., Munger, E. L., Hopkins, W. D., Ely, J. J., Erwin, J. M., Perl, D. P., Mufson, E. J., Hof, P. R., et al. (2018) · Journal of Comparative Neurology · doi:10.1002/cne.24484 · Cited by 34
Dehghani, Z., Meratan, A. A., Saboury, A. A., & Nemat‐Gorgani, M. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183251 · Cited by 35
Dabouz, R., Cheng, C. W. H., Abram, P., Omri, S., Cagnone, G., Sawmy, K. V., Joyal, J., Desjarlais, M., Olson, D. M., Weil, A. G., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02032-8 · Cited by 36
Coronavirus disease 2019 and neurodegenerative disease: what will the future bring?
McAlpine, L. S., Fesharaki‐Zadeh, A., & Spudich, S. (2020) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000688 · Cited by 38
Joaquim, L. D. S., Danielski, L. G., Bonfante, S., Biehl, E., Mathias, K., Denicol, T. L., Bagio, É., Lanzzarin, E., Machado, R. S., Bernades, G. C., et al. (2021) · International Journal of Neuroscience · doi:10.1080/00207454.2021.1922402 · Cited by 34
“pro-inflammatory mediators in the CNS diseases [50].”
NOX-induced oxidative stress is a primary trigger of major neurodegenerative disorders
Zilberter, Y., Tabuena, D. R., & Zilberter, M. Y. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102539 · Cited by 37
“Parkinson ’ s disease (PD), which is the second most common neurodegenerative disorder (Erkkinen et al., 2018) will also be discussed, along with frontotemporal dementia (FTD), a tauopathy (Yoshiyama et al., 2001; Y. Zhang et al., 2022) accounting for 10 – 20% of dementia cases and the second most common form of demen…”
InfluentialTengesdal, I. W., Banks, M., Dinarello, C. A., & Marchetti, C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1422249 · Cited by 41
“The role of NLRP3 in other sterile conditions has been more extensively reviewed elsewhere (15 – 17).”
BackgroundYu, K., Fu, L., Cao, Y., Zeng, X., Zhang, Y., Chen, Y., Gao, J., Lu, B., Zhu, H., Gu, L., et al. (2025) · ACS Nano · doi:10.1021/acsnano.4c18035 · Cited by 39
Moretti, S., Franchi, S., Castelli, M., Amodeo, G., Somaini, L., Panerai, A. E., & Sacerdote, P. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9592-2 · Cited by 37
“In addition to orchestrating peripheral immunity, cytokines are produced in the central and peripheral nervous systems by microglia and astrocytes (Block and Hong 2005; Di Filippo et al. 2008; Franchi et al. 2012; Heneka et al. 2014).”
The Role of Stefin B in Neuro-inflammation
Kopitar‐Jerala, N. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00458 · Cited by 34
“Recently, it was proposed that TLRs have an important role in the crosstalk between neurons and glial cells in the CNS. TLR signaling was linked to neurogenesis, it was also found to be involved in the pathogenesis of neurodegenerative diseases (Heneka et al., 2014).”
BackgroundDangguishaoyao-San attenuates LPS-induced neuroinflammation via the TLRs/NF-κB signaling pathway
Ding, R.-R., Chen, W., Guo, C.-Y., Liao, W.-T., Yang, X., Liao, F.-E., Lin, J.-M., Mei, H., & Zeng, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.108 · Cited by 34
Hu, Z., Deng, N., Liu, K., & Zeng, W. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113056 · Cited by 37
Stevens, A., Liu, L., Bertovich, D., Janjic, J. M., & Pollock, J. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215269 · Cited by 35
“Together with injured axons and activated Schwann cells, the infiltrating immune cells (macrophages, T cells, mast cells, and neutrophils) are crucial for normal function and recovery after nerve injury [17,24].”
BackgroundHaas, C. B., de Carvalho, A. K., Muller, A. P., Eggen, B. J. L., & Portela, L. V. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146884 · Cited by 215
The sTREM2 Concentrations in the Blood: A Marker of Neurodegeneration?
Ferri, E., Rossi, P. D., Geraci, A., Ciccone, S., Cesari, M., & Arosio, B. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.627931 · Cited by 41
“Indeed, aging is associated with gliosis, increased microglial activity (Heneka et al., 2014), and astrocytosis in the brain (Nichols et al.”
BackgroundSong, A., Yang, Y., He, H., Sun, J., Chang, Q., & Xue, Q. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s291274 · Cited by 35
Negative regulation of TREM2-mediated C9orf72 poly-GA clearance by the NLRP3 inflammasome
Shu, X., Chen, W., Tu, W.-Y., Zhong, K., Qi, S., Wang, A., Bai, L., Zhang, S.-X., Luo, B., Xu, Z., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112133 · Cited by 33
Pramotton, F. M., Spitz, S., & Kamm, R. D. (2024) · Advanced Science · doi:10.1002/advs.202403892 · Cited by 39
Atifi, M. E., Dreyfus, M., Berger, F. R., & Wion, D. (2015) · Neuroreport · doi:10.1097/wnr.0000000000000328 · Cited by 35
Next-generation profiling to identify the molecular etiology of Parkinson dementia
Henderson-Smith, A., Corneveaux, J. J., Both, M. D. D., Cuyugan, L., Liang, W. S., Huentelman, M. J., Adler, C. H., Driver‐Dunckley, E. D., Beach, T. G., & Dunckley, T. L. (2016) · Neurology Genetics · doi:10.1212/nxg.0000000000000075 · Cited by 37
Galectins in the brain: advances in neuroinflammation, neuroprotection and therapeutic opportunities
Barake, F., Soza, A., & González, A. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000812 · Cited by 33
Fung, S., Smith, C. S., Prater, K. E., Case, A., Green, K., Osnis, L., Winston, C. N., Kinoshita, Y., Sopher, B. L., Morrison, R. S., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200492 · Cited by 34
Sun, Y., Liu, Z., Pi, Z., Song, F., Wu, J., & Liu, S. (2021) · Phytotherapy Research · doi:10.1002/ptr.7014 · Cited by 34
“The chronic deposition of Aβ stimulates the persistent activation of microglial cells in AD (Heneka et al., 2013).”
BackgroundAhmed, S., Panda, S. R., Kwatra, M., Sahu, B. D., & Naidu, V. G. M. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00550 · Cited by 36
Yang, K.-L., Li, W., Liu, Y.-J., Wei, Y., Ren, Y., Mai, C., Zhang, S., Zuo, Y., Sun, Z., Li, D., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12091245 · Cited by 32
“NLRP3 is an impairing cellular function inflammasome, and the association between it and a number of neurodegeneration diseases has been extensively studied [15,16].”
BackgroundTargeting Insulin for Alzheimer’s Disease: Mechanisms, Status and Potential Directions
Lee, J. H., Jahrling, J. B., Denner, L. A., & Dineley, K. T. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179923 · Cited by 37
Neurodegenerative diseases and neuroinflammation-induced apoptosis
Huang, S., Lu, Y., Fang, W., Huang, Y., Li, Q., & Xu, Z. (2025) · Open Life Sciences · doi:10.1515/biol-2022-1051 · Cited by 39
Hypertension, blood–brain barrier disruption and changes in intracranial pressure
Colombari, E., Biancardi, V. C., Colombari, D. S. A., Katayama, P. L., Medeiros, F., Aitken, A. V., Xavier, C. H., Pedrino, G. R., & Bragin, D. E. (2025) · The Journal of Physiology · doi:10.1113/jp285058 · Cited by 43
“Specifically these molecules are produced by glial cells of the NVU, namely astrocytes and microglia, which exacerbate BBB disruption and increase cerebrovascular permeability (Heneka et al., 2014; Sofroniew, 2015).”
Phung, V. L. H., Ueda, K., Kasaoka, S., Seposo, X., Tasmin, S., Yonemochi, S., Phosri, A., Honda, A., Takano, H., Michikawa, T., et al. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15020307 · Cited by 30
“There are several possible pathways to the brain: (1) direct transportation of pollutant via circulatory pathway to the brain, passing through the BBB; (2) systemic inflammation whereby cytokines were circulated to the brain; and (3), the nose-to-brain route that bypasses the protective BBB whereby pollutants are tran…”
BackgroundAn, X.-Q., Xi, W., Gu, C.-Y., & Huang, X. (2018) · médecine/sciences · doi:10.1051/medsci/201834f120 · Cited by 31
“Treatment with Aβ oligomer in primary microglial cells can increase the expressions of IL-1β and TNF-α, which are significantly increased in serum and cerebrospinal fluid of AD patients [5,6].”
BackgroundHernández, E. R., Sánchez-Maldonado, C., Chávez, M. Á. M., Hernández-Zimbrón, L. F., Patricio-Martínez, A., Zenteno, E., & Limón, I. D. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1750955 · Cited by 35
Saroj, P., Bansal, Y., Singh, R., Akhtar, A., Sodhi, R. K., Bishnoi, M., Sah, S. P., & Kuhad, A. (2021) · Inflammopharmacology · doi:10.1007/s10787-020-00787-3 · Cited by 34
Elaidic acid induced NLRP3 inflammasome activation via ERS-MAPK signaling pathways in Kupffer cells
Liu, H., Nan, B., Yang, C., Li, X., Yan, H., & Yuan, Y. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159061 · Cited by 36
Ossola, B., Rifat, A., Rowland, A., Hunter, H., Drinkall, S., Bender, C., Hamlischer, M., Teall, M. R., Burley, R., Barker, D. F., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109330 · Cited by 30
“neurodegenerative disorders such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), Parkinson’s disease (PD) (Heneka et al., 2014; Thonhoff et al., 2018), and autoimmune disorders such as multiple sclerosis (Barclay and Shinohara, 2017).”
BackgroundTerpenes as Potential Anti-Alzheimer’s Disease Agents
Lima, E., & Medeiros, J. (2024) · Applied Sciences · doi:10.3390/app14093898 · Cited by 34
Lim, N. E., Yeo, B. S. Y., Lee, R. S., Lim, J. X., Chan, Y. H., Kandiah, N., Ho, R., Ho, C. S. H., Woo, J., Arai, H., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102470 · Cited by 35
Antonioni, A., Martorana, A., Santarnecchi, E., Hampel, H. J., & Koch, G. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70337 · Cited by 35
Chen, H., Li, Y., Gu, J., Yin, L., Bian, F., Su, L., Hong, Y., Deng, Y., & Chi, W. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.07.001 · Cited by 30
“…to adaptor apoptosis-associated speck-like protein containing a CARD (ASC) and recruit pro-caspase-1 to form a complex, which is named the inflammasome, providing a platform for caspase-1 to cleave pro-IL-1β into mature IL-1β (Broz and Dixit, 2016; Heneka et al., 2014; Lamkanfi and Dixit, 2014).”
BackgroundA metabolic perspective of late onset Alzheimer’s disease
Ettcheto, M., Cano, A. C., Busquets, O., Manzine, P. R., Sánchez‐López, E., Castro-Torres, R. D., Beas‐Zárate, C., Verdaguer, E., García, M. L., Olloquequi, J., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104255 · Cited by 34
A Therapeutic Strategy for Alzheimer's Disease Focused on Immune-inflammatory Modulation
Kim, S. H., Noh, M. Y., Kim, H.-J., Oh, K.-W., Park, J., Lee, S., Moon, Y., Kim, Y.-E., Bae, J. S., Jin, H. K., et al. (2019) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2019.18.2.33 · Cited by 30
Intracellular DAMPs in Neurodegeneration and Their Role in Clinical Therapeutics
Kaur, J., Singh, H., & Naqvi, S. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03289-9 · Cited by 33
“Most of the TLRs are expressed by the microglia which are scarcely present on the neurons and astrocytes [8, 124, 125].”
BackgroundEmerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder
Marchi, F. D., Franjkic, T., Schito, P., Russo, T., Nimac, J., Chami, A. A., Mele, A., Vidatic, L., Križ, J., Julien, J., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061599 · Cited by 31
“Among these, neuroinflammation is of major interest, since protein aggregates, mitochondrial damage and/or damaged/dying neurons directly trigger microglial activation [8].”
BackgroundKrishna, S., Dodd, C. A., & Filipov, N. M. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.01.038 · Cited by 32
“Besides inducing depression and anxiety, peripheral inflammatory events can influence the etiology and progression of many ongoing degenerative diseases, including AD and PD [7, 32].”
BackgroundCurcumin as a potential therapeutic agent for treating neurodegenerative diseases
Perales-Salinas, V., Purushotham, S. S., & Buskila, Y. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105790 · Cited by 34
“Glutamate excitotoxicity is another key factor in neurodegeneration and is influenced by oxidative stress, neuroinflammation, and impaired glial glutamate uptake (Heneka et al., 2014).”
BackgroundLiang, J.-H., Yu, H., Xia, C., Zheng, Y., Zhang, Z., Chen, Y., Raza, M. A., Wu, L. H., & Yan, H. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117006 · Cited by 33
Metadata
- Authors
- Heneka, M. T., Kummer, M. P., & Latz, E.
- Affiliations
- University of Bonn (DE)
- Corresponding author
- Heneka, Michael T.
- Venue
- Nature Reviews Immunology
- Published
- 2014-06-25
- Volume
- 14
- Issue
- 7
- Pages
- 463-477
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1986611577
- Cited by
- 1,437
- References
- 171
- Citations by year
- 2026: 109 · 2025: 137 · 2024: 118 · 2023: 104 · 2022: 125 · 2021: 143 · 2020: 158 · 2019: 117 · 2018: 116 · 2017: 106 · 2016: 96 · 2015: 97 · 2014: 9
- FWCI
- 8.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
- DZNE Pub (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- innate immunity, neurodegenerative diseases, neuroinflammation, microglia, NLRP3 inflammasome, NOD-like receptors, misfolded proteins, pro-inflammatory mediators, neuronal dysfunction, neuronal cell death, neurodegeneration therapy
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Brain, Carrier Proteins, Humans, Immunity, Innate, Inflammation, Signal Transduction, Cytokines, Amyloid beta-Peptides, Reactive Oxygen Species, Protein Folding, Microglia, Oxidative Stress, Neurodegenerative Diseases, Reactive Nitrogen Species, Receptors, Pattern Recognition, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.